Search

March 27 -- The Council for the Indian School Certificate Examinations (CISCE) on Tuesday postponed the 2024 ISC psychology examination that was slated on Wednesday March 27 as one of [...]

Local efforts to find a buyer for the closed Foley Cellulose Paper Mill in Perry have been put on hold for another year while owner Georgia Pacific conducts a study [...]

INTRODUCTION Aerosols can be defined as the suspension of solid or liquid particles in the air, which can be generated by either natural or anthropogenic phenomena, and may be present [...], Background Since the outbreak of COVID-19, how to reduce the risk of spreading viruses and other microorganisms while performing aerosol generating procedures (AGPs) has become a challenging question within the dental and dental hygiene communities. The purpose of this position paper is to summarize the existing evidence about the effectiveness of various mitigation methods used to reduce the risk of infection transmission during AGPs in dentistry. Methods The authors searched six databases, MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, and Google Scholar, for relevant scientific evidence published in the last ten years (January 2012 to December 2022) to answer six research questions about the the aspects of risk of transmission, methods, devices, and personal protective equipment (PPE) used to reduce contact with microbial pathogens and limit the spread of aerosols. Results A total of 78 studies fulfilled the eligibility criteria. There was limited literature to indicate the risk of infection transmission of SARS-CoV-2 between dental hygienists and their patients. A number of mouthrinses are effective in reducing bacterial contaminations in aerosols; however, their effectiveness against SARS-CoV-2 was limited. The combined use of eyewear, masks, and face shields are effective for the prevention of contamination of the facial and nasal region, while performing AGPs. High volume evacuation with or without an intraoral suction, low volume evacuation, saliva ejector, and rubber dam (when appropriate) have shown effectiveness in reducing aerosol transmission beyond the generation site. Finally, the appropriate combination of ventilation and filtration in dental operatories are effective in limiting the spread of aerosols. Conclusion Aerosols produced during clinical procedures can potentially pose a risk of infection transmission between dental hygienists and their patients. The implementation of practices supported by available evidence are best practices to ensure patient and provider safety in oral health settings. More studies in dental clinical environment would shape future practices and protocols, ultimately to ensure safe clinical care delivery. Keywords aerosol generating procedures, infectious disease transmission, respiratory aerosols and droplets, personal protective equipment, mouthrinses, SARS-CoV-2, COVID-19

2024 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Obesity, Fitness and Wellness. According to news [...]

Byline: Somnath Bera E-paper is continuously evolving. The day is not far when e-papers will replace the current OLED screens of mobiles and other handheld devices, resulting in significant reductions [...]

2024 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Cancer is the subject of a report. According to [...]

2024 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on colon cancer are discussed in a new report. According [...]

2024 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on OBGYN and Reproduction are discussed in a new report. According to [...]

NEC Corporation has released a white paper, 'Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines'. This white paper introduces (1) [...]

NEC is leveraging AI to develop personalized cancer vaccines targeting specific neoantigens. Their white paper outlines a workflow from design to administration, incorporating advanced ICT technologies for potential broader applications [...]